ANTI-TUMOR EFFECTS OF INTERLEUKIN-2 AND INTERLEUKIN-1 IN MICE TRANSPLANTED WITH DIFFERENT SYNGENEIC TUMORS

被引：33
作者：
BELARDELLI, F
CIOLLI, V
TESTA, U
MONTESORO, E
BULGARINI, D
PROIETTI, E
BORGHI, P
SESTILI, P
LOCARDI, C
PESCHLE, C
GRESSER, I
机构：
[1] IST SUPER SANITA,DEPT HEMATOL & ONCOL,I-00161 ROME,ITALY
[2] INST RECH SCI CANC,VIRAL ONCOL LAB,F-94802 VILLEJUIF,FRANCE
来源：
INTERNATIONAL JOURNAL OF CANCER | 1989年 / 44卷 / 06期
关键词：
D O I：
10.1002/ijc.2910440629
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1108 / 1116
页数：9
相关论文
共 37 条
[11]   ANTITUMOR EFFECTS OF INTERFERON IN MICE INJECTED WITH INTERFERON-SENSITIVE AND INTERFERON-RESISTANT FRIEND-LEUKEMIA CELLS .5. COMPARISONS WITH THE ACTION OF TUMOR-NECROSIS-FACTOR [J].
GRESSER, I ;
BELARDELLI, F ;
TAVERNIER, J ;
FIERS, W ;
PODO, F ;
FEDERICO, M ;
CARPINELLI, G ;
DUVILLARD, P ;
PRADE, M ;
MAURY, C ;
BANDU, MT ;
MAUNOURY, MT .
INTERNATIONAL JOURNAL OF CANCER, 1986, 38 (05) :771-778
[12]   EFFECTIVENESS OF MOUSE INTERFERON ALPHA-BETA-COMPARED TO SINGLE-AGENT CHEMOTHERAPY IN INCREASING SURVIVAL-TIME OF MICE AFTER INTRAVENOUS INOCULATION OF FRIEND-ERYTHROLEUKEMIA CELLS [J].
GRESSER, I ;
MAURY, C ;
BELARDELLI, F ;
MAUNOURY, MT ;
MACHOVER, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (02) :126-131
[13]   INJECTION OF MICE WITH ANTIBODY TO INTERFERON ENHANCES THE GROWTH OF TRANSPLANTABLE MURINE TUMORS [J].
GRESSER, I ;
BELARDELLI, F ;
MAURY, C ;
MAUNOURY, MT ;
TOVEY, MG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (06) :2095-2107
[14]   ANTITUMOR EFFECTS OF INTERFERON IN MICE INJECTED WITH INTERFERON-SENSITIVE AND INTERFERON-RESISTANT FRIEND-LEUKEMIA CELLS .6. ADJUVANT THERAPY AFTER SURGERY IN THE INHIBITION OF LIVER AND SPLEEN METASTASES [J].
GRESSER, I ;
MAURY, C ;
BELARDELLI, F .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (06) :789-792
[15]   INTERFERON TREATMENT MARKEDLY INHIBITS THE DEVELOPMENT OF TUMOR-METASTASES IN THE LIVER AND SPLEEN AND INCREASES SURVIVAL-TIME OF MICE AFTER INTRAVENOUS INOCULATION OF FRIEND-ERYTHROLEUKEMIA CELLS [J].
GRESSER, I ;
MAURY, C ;
WOODROW, D ;
MOSS, J ;
GRUTTER, MG ;
VIGNAUX, F ;
BELARDELLI, F ;
MAUNOURY, MT .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (01) :135-142
[16]  
KAYE J, 1984, J IMMUNOL, V133, P1339
[17]  
LAFRENIERE R, 1985, J IMMUNOL, V135, P4273
[18]  
LAFRENIERE R, 1985, CANCER RES, V45, P3735
[19]   HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN THE TREATMENT OF PATIENTS WITH DISSEMINATED CANCER - RESPONSES, TREATMENT-RELATED MORBIDITY, AND HISTOLOGIC-FINDINGS [J].
LOTZE, MT ;
CHANG, AE ;
SEIPP, CA ;
SIMPSON, C ;
VETTO, JT ;
ROSENBERG, SA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (22) :3117-3124
[20]   HUMAN INTERLEUKIN-2 - MOLECULAR-BIOLOGY, PHYSIOLOGY AND CLINICAL POSSIBILITIES [J].
MERTELSMANN, R ;
WELTE, K .
IMMUNOBIOLOGY, 1986, 172 (3-5) :400-419
1234